1-248638933-C-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001001827.2(OR2T35):c.326G>T(p.Gly109Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001827.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD3 exomes AF: 0.0000646 AC: 3AN: 46466Hom.: 0 AF XY: 0.000124 AC XY: 3AN XY: 24104
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000124 AC: 35AN: 281296Hom.: 0 Cov.: 4 AF XY: 0.000152 AC XY: 23AN XY: 151064
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.326G>T (p.G109V) alteration is located in exon 1 (coding exon 1) of the OR2T35 gene. This alteration results from a G to T substitution at nucleotide position 326, causing the glycine (G) at amino acid position 109 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at